IL17A and inflammatory bowel disease: Recent studies have found that IL-17 can promote the production of neutrophil chemokines in intestinal immunity, promote IBD response [28], and promote the secretion of pIgR (Ig receptor) and sIgA, which have anti-inflammatory effects [29].